More people receiving mental-health treatment does not necessarily mean fewer people reporting difficulties. England’s survey evidence shows both treatment use and common mental-health conditions increasing. Elsewhere in the UK, new reports track waiting times, well-being, and concerns using different measures. For families choosing private care, the question is what access changes and how recovery is measured afterward.
Key findings
47.7%: treatment use among adults aged 16 to 74 meeting England’s survey symptom threshold in 2023/24, compared with 24.4% in 2007. [1]
80.7%: Scottish psychological-therapy starters seen within eighteen weeks in the quarter ending June 2026, against a 90% standard. [2]
33%: respondents in Wales’s low-well-being category in 2024/25, reported in October 2026. This is not diagnosed depression prevalence. [3]
38%: Northern Ireland respondents reporting concerns about their mental health in the previous year, in the 2024/25 survey. These four indicators cannot be ranked as a single measure. [5]
England: treatment use nearly doubled
Treatment use increased by 23.3 percentage points between 2007 and 2023/24. Receiving treatment is not the same as receiving adequate care or reaching recovery. Source: Adult Psychiatric Morbidity Survey. [1]
A separate series, covering ages 16 to 64, puts common mental-health conditions at 17.6% in 2007, 18.9% in 2014, and 22.6% in 2023/24. Its denominator differs from the treatment-use series.
The findings do not show that treatment caused the prevalence change. Different people enter the survey groups at each point. Recognition, access, demand, and other factors would need separate analysis.
Scotland: better waiting-time performance, still below target
The September 2026 release reports 80.7% starting within eighteen weeks in the June quarter, compared with 78.7% the preceding quarter and 78.5% a year earlier. Half began within five weeks. The measure covers people who started therapy, not everyone still waiting. [2]
The release includes NHS Golden Jubilee data throughout its comparison period. Using that internally consistent history avoids joining it to older totals that excluded those records.
A national waiting-time measure does not predict an individual’s wait or eventual clinical result. It describes access, which should be evaluated separately from effectiveness.
Wales: a new report is not a new observation year
The report published October 1, 2026 uses adult well-being observations from 2024/25. The average Warwick-Edinburgh Mental Well-being Scale score was 48.4, with 33% classified as low, 52% medium, and 15% high. [3]
Those are well-being categories, not diagnostic prevalence estimates. The equality chapter also warns that the smaller survey sample was less representative, including fewer people from low-income areas. Small subgroup differences need care. [4]
For research readers, both dates matter: when the report appeared and when people answered the questions. Calling these 2026 prevalence figures would change their meaning.
Northern Ireland: a social difference is not a wealth study
The 2024/25 survey found 38% reporting mental-health concerns during the previous year, compared with 32% in 2022/23. A different measure, a high GHQ12 score indicating potential mental-health problems, was recorded for 24% in the most-deprived areas and 14% in the least-deprived areas. [5]
The difference is ten percentage points. Neighborhood deprivation is not individual net worth, and the association is not proof of causation. Source: NISRA and Department of Health. [5]
The more advantaged-area estimate is lower, not zero. That does not justify claiming wealthy people have the highest burden, or assuming financial security rules out a need for care.
Four nations, four questions
| Scope | Figure | Period | Measure |
|---|---|---|---|
| England | 47.7% | 2023/24 | Treatment use among a symptomatic survey group |
| Scotland | 80.7% | June 2026 quarter | Therapy starters seen within eighteen weeks |
| Wales | 33% | 2024/25 | Low-well-being classification |
| Northern Ireland | 38% | 2024/25 | Past-year mental-health concerns |
A genuine prevalence comparison needs compatible questions, ages, periods, and sampling. The percentages above answer different questions and should not be ranked by size.
Work-related costs add another measure
HSE estimates 22.1 million working days lost to work-related stress, depression, or anxiety in Great Britain in 2024/25, averaging 22.9 days per affected case. Great Britain excludes Northern Ireland. The category is not identical to burnout or all mental illness. [6]
For a founder or senior professional, the useful next question is what returning to work should measure beyond attendance. The national estimate does not isolate executives. Multiplying it by senior salaries would not produce a defensible cost of executive distress.
An individual recovery plan can consider concentration, sustainable responsibilities, and personal goals alongside symptoms. Working through difficulty is not itself evidence that no problem exists.
Private access needs an outcome question
The ability to pay can widen the choices without establishing the right diagnosis, setting, or treatment. Ask why the proposed pathway fits the clinical assessment and what evidence supports any claimed advantage.
A satisfaction percentage cannot be ranked against an NHS clinical recovery rate. A meaningful comparison needs compatible patients, outcomes, and observation periods.
The standard applies to THE BALANCE too: explain who was included, what counted as improvement, how long follow-up lasted, and how much information was missing.
A change of country does not complete the handover
A UK resident receiving care abroad may return to a different clinical team. Confirm who will receive the history, what has been agreed, and how progress will be reviewed.
A list of possible clinicians is not an accepted receiving arrangement. Work, family, and travel can make the first weeks after discharge harder to organize, even where resources are available.
Remote treatment and prescribing should follow the relevant requirements. This article does not establish a universal permission to deliver clinical care across countries.
Freshness also means recognizing corrections
The APMS publication withdrew its autism chapter and tables on May 18, 2026 after identifying a processing error. Those estimates are not used here. A research publication should follow corrections as carefully as new releases. [1]
The same principle explains using revised Scottish comparisons and dating the Welsh observations accurately. A methodological change, a publication date, and a change in health are different events.
The bottom line
The evidence contains increased treatment use, persistent social differences, improved access on some measures, and continuing gaps. It is neither a simple national failure story nor proof that more provision automatically creates more recovery. Families choosing private care should ask about clinical fit and sustained outcomes as carefully as access.
For journalists
Key finding: England’s treatment-use estimate among symptomatic adults increased by 23.3 percentage points between 2007 and 2023/24.
Important caveat: England’s survey is not UK-wide; the other nations’ indicators measure different things.
Suggested attribution: THE BALANCE analysis of official UK-nation mental-health publications.
Methodology and sources
This narrative analysis uses the source periods and definitions in the existing research record, with an October 6, 2026 evidence cutoff. It does not calculate pooled UK prevalence, an HNW rate, or a private-versus-public treatment effect.
- NHS England. Adult Psychiatric Morbidity Survey, 2023/24, with 2026 correction notice.
- Public Health Scotland. Psychological therapies waiting times, June 2026 quarter. September 1, 2026.
- Welsh Government. Wellbeing of Wales 2026: a healthier Wales.
- Welsh Government. Wellbeing of Wales 2026: a more equal Wales.
- NISRA. Health Survey Northern Ireland 2024/25 findings. November 26, 2025.
- HSE. Working days lost, 2024/25.


